Skip to main content

View full-text article in PMC

. 2018 May 8;17:102. doi: 10.1186/s12944-018-0676-x

Table 2.

All-cause mortality and cardio-cerebrovascular events mortality (/1000 persons/year)

Patients	Group	All-cause death	Mortality (95%CI)	Cardio-cerebrovascular events death	Mortality (95%CI)
Total	Diabetes	18	4.5 (3.67–5.98)	5	1.3 (0.98–1.65)
Total	Diabetes combined with hyperlipidemia	32	8.4 (6.09–9.24)^a	14	3.7 (2.97–4.02)^a
< 65 years	Diabetes	9	2.2 (1.87–2.48)	3	0.6 (0.38–0.78)
< 65 years	Diabetes combined with hyperlipidemia	21	5.4 (4.81–5.94)^a	8	1.7 (1.42–2.02)^a
≥ 65 years	Diabetes	26	5.2 (4.89–5.42)	5	0.9 (0.88–1.02)
≥ 65 years	Diabetes combined with hyperlipidemia	23	5.4 (5.11–5.64)	6	1.1 (0.97–1.12)
Female	Diabetes	5	1.1 (0.87–1.28)	2	0.4 (0.28–0.53)
Female	Diabetes combined with hyperlipidemia	17	4.4 (4.22–4.74)^a	7	1.5 (1.42–1.62)^a
Male	Diabetes	11	3.1 (2.87–3.28)	4	0.7 (0.64–0.83)
Male	Diabetes combined with hyperlipidemia	25	4.9 (4.82–5.14)^a	9	1.9 (1.83–2.02)^a
Family history	Diabetes	10	2.8 (2.57–2.98)	6	0.6 (0.58–0.73)
	Diabetes combined with hyperlipidemia	25	5.9 (5.53–6.14)^a	12	1.9 (1.83–2.02)^a
No family history	Diabetes	17	3.6 (3.37–3.88)	10	1.6 (1.48–1.73)
	Diabetes combined with hyperlipidemia	20	3.9 (3.53–4.14)	12	1.9 (1.83–2.02)

CI confidence interval

Note: ^aP < 0.05, which is compared with the same patients in diabetes group